Centogene_Logo.png
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
19 mars 2024 06h30 HE | Centogene NV
Longstanding global partnership provides an efficient and timely diagnosis to patients with Lysosomal Storage Disorders (LSDs) CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 19, 2024 ...
Centogene_Logo.png
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
11 avr. 2023 06h30 HE | Centogene NV
The global market access and expansion partnership, initially established in 2015, aims to provide an efficient and timely diagnosis to patients with Lysosomal Storage Disorders (LSDs) Diagnosis...
Ribbon cutting ceremony.
Takeda’s Area Offices in Dubai, United Arab Emirates Certified Sustainable and Inaugurated
16 nov. 2021 07h53 HE | Takeda Pharmaceuticals
Dubai, United Arab Emirates, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Recognizing that climate change poses a risk to human health, including the spread of infectious diseases, Takeda has made...
Takeda and Frazier H
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
30 juil. 2021 05h50 HE | Takeda Pharmaceuticals
Dubai, United Arab Emirates, July 30, 2021 (GLOBE NEWSWIRE) -- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a...